Share Price and Basic Stock Data
Last Updated: January 15, 2026, 5:39 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Aksh Optifibre Ltd operates within the telecom cable industry, with its share price currently standing at ₹5.94 and a market capitalization of ₹96.6 Cr. The company reported sales of ₹286 Cr for the fiscal year ending March 2023, reflecting a decline from ₹316 Cr in the previous year. Sales have shown volatility, with quarterly revenues peaking at ₹79.57 Cr in March 2023, before declining to ₹60.34 Cr in September 2023. The overall trend indicates challenges in maintaining consistent revenue growth, as sales for the trailing twelve months (TTM) calculate to ₹120 Cr, compared to ₹220 Cr expected for March 2024. This downward trajectory raises questions about market demand and competitive positioning, particularly given the sector’s reliance on technological advancements and infrastructure investments. The company’s operational performance is further complicated by fluctuating expenses, which stood at ₹239 Cr in FY 2023, suggesting tight margins and potential inefficiencies in cost management.
Profitability and Efficiency Metrics
Profitability metrics for Aksh Optifibre exhibit significant challenges, with a reported net profit of -₹21 Cr for the latest fiscal year. The operating profit margin (OPM) has deteriorated to 5.16%, down from higher levels in previous years, indicating pressure on profitability. Quarterly results reveal an alarming trend, with OPM plummeting to a mere 3.36% in September 2023 and dipping to negative margins in subsequent quarters. The interest coverage ratio (ICR) is notably low at -0.25x, underscoring difficulties in meeting interest obligations, a critical concern for financial stability. The return on equity (ROE) is exceptionally high at 113%, but this figure is misleading due to negative net profit, indicating that equity is being eroded rather than generating returns. Furthermore, the cash conversion cycle (CCC) stood at -46 days for the latest period, which, while indicating efficient cash flow management, also raises questions about the sustainability of revenue generation amidst declining sales.
Balance Sheet Strength and Financial Ratios
The balance sheet of Aksh Optifibre reveals concerning financial health, with total borrowings reported at ₹100 Cr and reserves declining to -₹83 Cr as of September 2025. This negative reserve indicates that the company has more liabilities than equity, a situation that is unsustainable in the long term. The book value per share, including revaluation reserves, is reported at ₹0.71, while the price-to-book value (P/BV) stands at -18.20x, reflecting market skepticism regarding the company’s asset valuation and future prospects. The current ratio is low at 0.65x, indicating potential liquidity issues, especially in meeting short-term obligations. Additionally, the total debt-to-equity ratio is reported at -11.37, suggesting an alarming level of financial leverage that could pose risks if the company fails to stabilize its earnings. These financial ratios highlight the urgent need for strategic restructuring and improved operational efficiencies to restore investor confidence and financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Aksh Optifibre indicates a significant shift in investor confidence, with promoter holdings declining from 27.95% in December 2022 to 19.73% by September 2025. This reduction, alongside minimal foreign institutional investment (FIIs) at 0.07%, suggests a lack of confidence from institutional investors. Domestic institutional investors (DIIs) hold a negligible 0.01%, while public shareholding has risen to 80.20%, indicating a shift towards retail investment. The total number of shareholders has also decreased to 72,095, reflecting a potential exit by institutional players. The declining promoter stake and increasing public shareholding may signal a lack of strategic direction or confidence in future performance, which could further impact the stock’s liquidity and market perception. Investor sentiment appears cautious, as evidenced by the company’s financial struggles and the significant drop in operational profitability.
Outlook, Risks, and Final Insight
Looking ahead, Aksh Optifibre faces several critical risks that could impede recovery, including deteriorating profitability, high debt levels, and declining investor confidence. The company’s ability to stabilize revenues amid a challenging market environment is uncertain, particularly given the significant drop in sales projections. However, potential strengths include a high ROE, indicating efficient use of equity capital, and a robust cash conversion cycle, which may provide some liquidity flexibility. To navigate these challenges, the company must focus on operational efficiency, cost management, and potentially restructuring its debt to improve its financial health. If successful, Aksh Optifibre could leverage its existing market position to regain investor confidence and stabilize its financial performance. Conversely, failure to address these financial and operational challenges could lead to further declines in market capitalization and shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Vindhya Telelinks Ltd | 1,533 Cr. | 1,294 | 1,890/1,155 | 5.75 | 3,585 | 1.24 % | 7.64 % | 5.03 % | 10.0 |
| Tamil Nadu Telecommunications Ltd | 44.4 Cr. | 9.71 | 26.1/7.66 | 41.0 | 0.00 % | % | % | 10.0 | |
| Surana Telecom and Power Ltd | 262 Cr. | 19.3 | 29.3/15.5 | 11.1 | 11.9 | 0.00 % | 0.69 % | 0.37 % | 1.00 |
| Sterlite Technologies Ltd | 4,592 Cr. | 94.1 | 140/52.2 | 1,148 | 42.1 | 0.00 % | 2.86 % | 6.28 % | 2.00 |
| Paramount Communications Ltd | 1,067 Cr. | 35.0 | 78.0/34.0 | 14.6 | 24.6 | 0.00 % | 16.3 % | 12.8 % | 2.00 |
| Industry Average | 1,570.40 Cr | 227.29 | 251.73 | 542.13 | 0.18% | 7.67% | 23.24% | 5.71 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 58.69 | 68.32 | 79.57 | 57.93 | 60.34 | 51.72 | 50.29 | 41.95 | 26.12 | 28.99 | 32.98 | 26.95 | 31.19 |
| Expenses | 50.45 | 55.95 | 67.03 | 50.19 | 58.31 | 48.69 | 51.05 | 42.35 | 30.05 | 29.81 | 32.87 | 27.87 | 29.58 |
| Operating Profit | 8.24 | 12.37 | 12.54 | 7.74 | 2.03 | 3.03 | -0.76 | -0.40 | -3.93 | -0.82 | 0.11 | -0.92 | 1.61 |
| OPM % | 14.04% | 18.11% | 15.76% | 13.36% | 3.36% | 5.86% | -1.51% | -0.95% | -15.05% | -2.83% | 0.33% | -3.41% | 5.16% |
| Other Income | 0.62 | 0.50 | -13.01 | 0.18 | 6.64 | 1.67 | -58.58 | 0.20 | 2.50 | 0.51 | 1.72 | -0.71 | 0.65 |
| Interest | 5.38 | 3.30 | 4.44 | 4.14 | 3.84 | 3.38 | 4.44 | 3.34 | 2.22 | 2.48 | 5.60 | 3.03 | 2.87 |
| Depreciation | 6.15 | 6.30 | 6.21 | 5.59 | 5.50 | 5.45 | 4.69 | 3.04 | 3.22 | 2.87 | 4.42 | 3.01 | 2.81 |
| Profit before tax | -2.67 | 3.27 | -11.12 | -1.81 | -0.67 | -4.13 | -68.47 | -6.58 | -6.87 | -5.66 | -8.19 | -7.67 | -3.42 |
| Tax % | -0.00% | 63.61% | 20.77% | -0.55% | 635.82% | 1.94% | -11.83% | -16.26% | 32.02% | -16.25% | -18.80% | -15.78% | -10.82% |
| Net Profit | -2.67 | 1.19 | -13.44 | -1.80 | -4.93 | -4.21 | -60.37 | -5.52 | -9.07 | -4.74 | -6.65 | -6.46 | -3.05 |
| EPS in Rs | -0.16 | 0.07 | -0.83 | -0.11 | -0.30 | -0.26 | -3.71 | -0.34 | -0.56 | -0.29 | -0.41 | -0.40 | -0.19 |
Last Updated: January 13, 2026, 5:16 am
Below is a detailed analysis of the quarterly data for Aksh Optifibre Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 31.19 Cr.. The value appears strong and on an upward trend. It has increased from 26.95 Cr. (Jun 2025) to 31.19 Cr., marking an increase of 4.24 Cr..
- For Expenses, as of Sep 2025, the value is 29.58 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.87 Cr. (Jun 2025) to 29.58 Cr., marking an increase of 1.71 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.61 Cr.. The value appears strong and on an upward trend. It has increased from -0.92 Cr. (Jun 2025) to 1.61 Cr., marking an increase of 2.53 Cr..
- For OPM %, as of Sep 2025, the value is 5.16%. The value appears strong and on an upward trend. It has increased from -3.41% (Jun 2025) to 5.16%, marking an increase of 8.57%.
- For Other Income, as of Sep 2025, the value is 0.65 Cr.. The value appears strong and on an upward trend. It has increased from -0.71 Cr. (Jun 2025) to 0.65 Cr., marking an increase of 1.36 Cr..
- For Interest, as of Sep 2025, the value is 2.87 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.03 Cr. (Jun 2025) to 2.87 Cr., marking a decrease of 0.16 Cr..
- For Depreciation, as of Sep 2025, the value is 2.81 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.01 Cr. (Jun 2025) to 2.81 Cr., marking a decrease of 0.20 Cr..
- For Profit before tax, as of Sep 2025, the value is -3.42 Cr.. The value appears strong and on an upward trend. It has increased from -7.67 Cr. (Jun 2025) to -3.42 Cr., marking an increase of 4.25 Cr..
- For Tax %, as of Sep 2025, the value is -10.82%. The value appears to be increasing, which may not be favorable. It has increased from -15.78% (Jun 2025) to -10.82%, marking an increase of 4.96%.
- For Net Profit, as of Sep 2025, the value is -3.05 Cr.. The value appears strong and on an upward trend. It has increased from -6.46 Cr. (Jun 2025) to -3.05 Cr., marking an increase of 3.41 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.19. The value appears strong and on an upward trend. It has increased from -0.40 (Jun 2025) to -0.19, marking an increase of 0.21.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 239 | 356 | 449 | 489 | 618 | 530 | 300 | 272 | 316 | 286 | 220 | 130 | 120 |
| Expenses | 204 | 307 | 372 | 439 | 544 | 447 | 294 | 247 | 266 | 239 | 268 | 135 | 120 |
| Operating Profit | 35 | 49 | 77 | 50 | 74 | 84 | 7 | 26 | 51 | 48 | -47 | -5 | -0 |
| OPM % | 14% | 14% | 17% | 10% | 12% | 16% | 2% | 9% | 16% | 17% | -22% | -4% | -0% |
| Other Income | 9 | 5 | -12 | 4 | 1 | 6 | -317 | 3 | 5 | -11 | 9 | 5 | 2 |
| Interest | 7 | 11 | 15 | 15 | 19 | 32 | 31 | 29 | 26 | 18 | 16 | 14 | 14 |
| Depreciation | 15 | 17 | 21 | 22 | 24 | 30 | 25 | 25 | 24 | 25 | 21 | 14 | 13 |
| Profit before tax | 22 | 26 | 29 | 18 | 33 | 27 | -366 | -25 | 6 | -7 | -75 | -27 | -25 |
| Tax % | 0% | 3% | 13% | 47% | 36% | 61% | -2% | 1% | 107% | 100% | -5% | -5% | |
| Net Profit | 22 | 25 | 26 | 10 | 21 | 11 | -359 | -25 | -0 | -14 | -71 | -26 | -21 |
| EPS in Rs | 1.46 | 1.67 | 1.57 | 0.59 | 1.28 | 0.66 | -22.08 | -1.56 | -0.03 | -0.83 | -4.38 | -1.60 | -1.29 |
| Dividend Payout % | 22% | 0% | 0% | 0% | 23% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 13.64% | 4.00% | -61.54% | 110.00% | -47.62% | -3363.64% | 93.04% | 100.00% | -407.14% | 63.38% |
| Change in YoY Net Profit Growth (%) | 0.00% | -9.64% | -65.54% | 171.54% | -157.62% | -3316.02% | 3456.67% | 6.96% | -507.14% | 470.52% |
Aksh Optifibre Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -15% |
| 3 Years: | -26% |
| TTM: | -44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | % |
| TTM: | -46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | 1% |
| 3 Years: | -17% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -32% |
| 3 Years: | -58% |
| Last Year: | -113% |
Last Updated: September 4, 2025, 10:40 pm
Balance Sheet
Last Updated: December 10, 2025, 2:20 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 96 | 98 | 103 | 81 | 81 | 81 | 81 | 81 | 81 | 81 | 81 | 81 | 81 |
| Reserves | 279 | 311 | 357 | 381 | 402 | 412 | 46 | 22 | 22 | -6 | -41 | -70 | -83 |
| Borrowings | 135 | 142 | 109 | 150 | 270 | 310 | 269 | 245 | 210 | 183 | 102 | 99 | 100 |
| Other Liabilities | 70 | 98 | 104 | 146 | 187 | 200 | 200 | 165 | 164 | 118 | 189 | 171 | 184 |
| Total Liabilities | 581 | 649 | 673 | 758 | 941 | 1,003 | 597 | 513 | 477 | 376 | 331 | 282 | 282 |
| Fixed Assets | 98 | 123 | 108 | 119 | 248 | 244 | 260 | 238 | 215 | 191 | 122 | 111 | 106 |
| CWIP | 161 | 147 | 151 | 170 | 165 | 240 | 94 | 92 | 92 | 92 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 322 | 380 | 414 | 469 | 528 | 519 | 243 | 183 | 170 | 94 | 210 | 171 | 176 |
| Total Assets | 581 | 649 | 673 | 758 | 941 | 1,003 | 597 | 513 | 477 | 376 | 331 | 282 | 282 |
Below is a detailed analysis of the balance sheet data for Aksh Optifibre Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 81.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 81.00 Cr..
- For Reserves, as of Sep 2025, the value is -83.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -70.00 Cr. (Mar 2025) to -83.00 Cr., marking a decline of 13.00 Cr..
- For Borrowings, as of Sep 2025, the value is 100.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 99.00 Cr. (Mar 2025) to 100.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 184.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 171.00 Cr. (Mar 2025) to 184.00 Cr., marking an increase of 13.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 282.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 282.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 106.00 Cr.. The value appears to be declining and may need further review. It has decreased from 111.00 Cr. (Mar 2025) to 106.00 Cr., marking a decrease of 5.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 176.00 Cr.. The value appears strong and on an upward trend. It has increased from 171.00 Cr. (Mar 2025) to 176.00 Cr., marking an increase of 5.00 Cr..
- For Total Assets, as of Sep 2025, the value is 282.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 282.00 Cr..
However, the Borrowings (100.00 Cr.) are higher than the Reserves (-83.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -100.00 | -93.00 | -32.00 | -100.00 | -196.00 | -226.00 | -262.00 | -219.00 | -159.00 | -135.00 | -149.00 | -104.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 65 | 153 | 135 | 141 | 145 | 132 | 121 | 103 | 91 | 50 | 40 | 60 |
| Inventory Days | 65 | 48 | 34 | 55 | 52 | 150 | 135 | 122 | 94 | 50 | 54 | 64 |
| Days Payable | 110 | 101 | 100 | 118 | 104 | 144 | 191 | 228 | 191 | 107 | 150 | 170 |
| Cash Conversion Cycle | 19 | 100 | 69 | 79 | 94 | 137 | 65 | -3 | -6 | -8 | -55 | -46 |
| Working Capital Days | 272 | 209 | 178 | 116 | 72 | 80 | -150 | -286 | -223 | -245 | -14 | -87 |
| ROCE % | 5% | 7% | 9% | 6% | 8% | 7% | -3% | 1% | 9% | 9% | -33% | -13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -1.60 | -4.38 | -0.83 | -0.03 | -1.56 |
| Diluted EPS (Rs.) | -1.60 | -4.38 | -0.83 | -0.03 | -1.56 |
| Cash EPS (Rs.) | -0.76 | -3.08 | 0.67 | 1.44 | -0.05 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -0.43 | 1.34 | 4.64 | 6.37 | 6.34 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 0.71 | 2.49 | 4.64 | 6.37 | 6.34 |
| Revenue From Operations / Share (Rs.) | 7.99 | 13.54 | 17.61 | 19.44 | 16.73 |
| PBDIT / Share (Rs.) | -0.21 | -2.81 | 3.10 | 3.40 | 1.83 |
| PBIT / Share (Rs.) | -1.05 | -4.12 | 1.59 | 1.93 | 0.32 |
| PBT / Share (Rs.) | -1.68 | -4.61 | -0.41 | 0.36 | -1.54 |
| Net Profit / Share (Rs.) | -1.60 | -4.38 | -0.83 | -0.02 | -1.56 |
| NP After MI And SOA / Share (Rs.) | -1.60 | -4.38 | -0.83 | -0.02 | -1.56 |
| PBDIT Margin (%) | -2.69 | -20.77 | 17.60 | 17.46 | 10.94 |
| PBIT Margin (%) | -13.11 | -30.40 | 9.03 | 9.92 | 1.93 |
| PBT Margin (%) | -20.99 | -34.08 | -2.36 | 1.85 | -9.20 |
| Net Profit Margin (%) | -19.96 | -32.36 | -4.73 | -0.13 | -9.32 |
| NP After MI And SOA Margin (%) | -19.96 | -32.36 | -4.73 | -0.13 | -9.32 |
| Return on Networth / Equity (%) | 0.00 | -327.10 | -17.99 | -0.40 | -24.61 |
| Return on Capital Employeed (%) | -52.50 | -105.09 | 23.54 | 21.75 | 3.44 |
| Return On Assets (%) | -9.22 | -21.47 | -3.57 | -0.08 | -4.95 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.10 | 0.21 |
| Total Debt / Equity (X) | -11.37 | 3.92 | 2.11 | 1.75 | 2.12 |
| Asset Turnover Ratio (%) | 0.42 | 0.61 | 0.66 | 0.57 | 0.43 |
| Current Ratio (X) | 0.65 | 0.76 | 0.31 | 0.48 | 0.46 |
| Quick Ratio (X) | 0.59 | 0.67 | 0.22 | 0.35 | 0.33 |
| Inventory Turnover Ratio (X) | 6.78 | 6.19 | 3.67 | 3.38 | 2.36 |
| Interest Coverage Ratio (X) | -0.25 | -2.90 | 2.73 | 2.16 | 1.01 |
| Interest Coverage Ratio (Post Tax) (X) | -1.15 | -4.00 | 1.04 | 0.98 | 0.16 |
| Enterprise Value (Cr.) | 189.16 | 196.40 | 290.46 | 325.50 | 283.76 |
| EV / Net Operating Revenue (X) | 1.45 | 0.89 | 1.01 | 1.03 | 1.04 |
| EV / EBITDA (X) | -54.01 | -4.29 | 5.76 | 5.89 | 9.53 |
| MarketCap / Net Operating Revenue (X) | 0.98 | 0.59 | 0.48 | 0.51 | 0.31 |
| Price / BV (X) | -18.20 | 6.05 | 1.83 | 1.57 | 0.83 |
| Price / Net Operating Revenue (X) | 0.98 | 0.59 | 0.48 | 0.51 | 0.31 |
| EarningsYield | -0.20 | -0.54 | -0.09 | 0.00 | -0.29 |
After reviewing the key financial ratios for Aksh Optifibre Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -1.60. This value is below the healthy minimum of 5. It has increased from -4.38 (Mar 24) to -1.60, marking an increase of 2.78.
- For Diluted EPS (Rs.), as of Mar 25, the value is -1.60. This value is below the healthy minimum of 5. It has increased from -4.38 (Mar 24) to -1.60, marking an increase of 2.78.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.76. This value is below the healthy minimum of 3. It has increased from -3.08 (Mar 24) to -0.76, marking an increase of 2.32.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -0.43. It has decreased from 1.34 (Mar 24) to -0.43, marking a decrease of 1.77.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 0.71. It has decreased from 2.49 (Mar 24) to 0.71, marking a decrease of 1.78.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 7.99. It has decreased from 13.54 (Mar 24) to 7.99, marking a decrease of 5.55.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.21. This value is below the healthy minimum of 2. It has increased from -2.81 (Mar 24) to -0.21, marking an increase of 2.60.
- For PBIT / Share (Rs.), as of Mar 25, the value is -1.05. This value is below the healthy minimum of 0. It has increased from -4.12 (Mar 24) to -1.05, marking an increase of 3.07.
- For PBT / Share (Rs.), as of Mar 25, the value is -1.68. This value is below the healthy minimum of 0. It has increased from -4.61 (Mar 24) to -1.68, marking an increase of 2.93.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.60. This value is below the healthy minimum of 2. It has increased from -4.38 (Mar 24) to -1.60, marking an increase of 2.78.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -1.60. This value is below the healthy minimum of 2. It has increased from -4.38 (Mar 24) to -1.60, marking an increase of 2.78.
- For PBDIT Margin (%), as of Mar 25, the value is -2.69. This value is below the healthy minimum of 10. It has increased from -20.77 (Mar 24) to -2.69, marking an increase of 18.08.
- For PBIT Margin (%), as of Mar 25, the value is -13.11. This value is below the healthy minimum of 10. It has increased from -30.40 (Mar 24) to -13.11, marking an increase of 17.29.
- For PBT Margin (%), as of Mar 25, the value is -20.99. This value is below the healthy minimum of 10. It has increased from -34.08 (Mar 24) to -20.99, marking an increase of 13.09.
- For Net Profit Margin (%), as of Mar 25, the value is -19.96. This value is below the healthy minimum of 5. It has increased from -32.36 (Mar 24) to -19.96, marking an increase of 12.40.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -19.96. This value is below the healthy minimum of 8. It has increased from -32.36 (Mar 24) to -19.96, marking an increase of 12.40.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -327.10 (Mar 24) to 0.00, marking an increase of 327.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is -52.50. This value is below the healthy minimum of 10. It has increased from -105.09 (Mar 24) to -52.50, marking an increase of 52.59.
- For Return On Assets (%), as of Mar 25, the value is -9.22. This value is below the healthy minimum of 5. It has increased from -21.47 (Mar 24) to -9.22, marking an increase of 12.25.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is -11.37. This value is within the healthy range. It has decreased from 3.92 (Mar 24) to -11.37, marking a decrease of 15.29.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. It has decreased from 0.61 (Mar 24) to 0.42, marking a decrease of 0.19.
- For Current Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1.5. It has decreased from 0.76 (Mar 24) to 0.65, marking a decrease of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.59, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.78. This value is within the healthy range. It has increased from 6.19 (Mar 24) to 6.78, marking an increase of 0.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -0.25. This value is below the healthy minimum of 3. It has increased from -2.90 (Mar 24) to -0.25, marking an increase of 2.65.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.15. This value is below the healthy minimum of 3. It has increased from -4.00 (Mar 24) to -1.15, marking an increase of 2.85.
- For Enterprise Value (Cr.), as of Mar 25, the value is 189.16. It has decreased from 196.40 (Mar 24) to 189.16, marking a decrease of 7.24.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.45. This value is within the healthy range. It has increased from 0.89 (Mar 24) to 1.45, marking an increase of 0.56.
- For EV / EBITDA (X), as of Mar 25, the value is -54.01. This value is below the healthy minimum of 5. It has decreased from -4.29 (Mar 24) to -54.01, marking a decrease of 49.72.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 24) to 0.98, marking an increase of 0.39.
- For Price / BV (X), as of Mar 25, the value is -18.20. This value is below the healthy minimum of 1. It has decreased from 6.05 (Mar 24) to -18.20, marking a decrease of 24.25.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 24) to 0.98, marking an increase of 0.39.
- For EarningsYield, as of Mar 25, the value is -0.20. This value is below the healthy minimum of 5. It has increased from -0.54 (Mar 24) to -0.20, marking an increase of 0.34.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aksh Optifibre Ltd:
- Net Profit Margin: -19.96%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -52.5% (Industry Average ROCE: 7.67%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 23.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.15
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.59
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 251.73)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -11.37
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -19.96%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cables - Telecom | F-1080, RIICO Industrial Area, Phase-III, Bhiwadi Rajasthan 301019 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Kailash Shantilal Choudhari | Chairman & Non-Exe.Director |
| Mr. Satyendra Kumar Gupta | Vice Chairman & Non Exe.Dire |
| Mr. Sanjay Katyal | Independent Director |
| Ms. Anuja Bansal | Independent Director |
| Mr. Sunil Puri | Independent Director |
| Mr. Harvinder Singh | Independent Director |
FAQ
What is the intrinsic value of Aksh Optifibre Ltd?
Aksh Optifibre Ltd's intrinsic value (as of 15 January 2026) is ₹1.24 which is 79.16% lower the current market price of ₹5.95, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹96.8 Cr. market cap, FY2025-2026 high/low of ₹13.0/5.55, reserves of ₹-83 Cr, and liabilities of ₹282 Cr.
What is the Market Cap of Aksh Optifibre Ltd?
The Market Cap of Aksh Optifibre Ltd is 96.8 Cr..
What is the current Stock Price of Aksh Optifibre Ltd as on 15 January 2026?
The current stock price of Aksh Optifibre Ltd as on 15 January 2026 is ₹5.95.
What is the High / Low of Aksh Optifibre Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Aksh Optifibre Ltd stocks is ₹13.0/5.55.
What is the Stock P/E of Aksh Optifibre Ltd?
The Stock P/E of Aksh Optifibre Ltd is .
What is the Book Value of Aksh Optifibre Ltd?
The Book Value of Aksh Optifibre Ltd is 0.09.
What is the Dividend Yield of Aksh Optifibre Ltd?
The Dividend Yield of Aksh Optifibre Ltd is 0.00 %.
What is the ROCE of Aksh Optifibre Ltd?
The ROCE of Aksh Optifibre Ltd is 13.4 %.
What is the ROE of Aksh Optifibre Ltd?
The ROE of Aksh Optifibre Ltd is 113 %.
What is the Face Value of Aksh Optifibre Ltd?
The Face Value of Aksh Optifibre Ltd is 5.00.